Continental Chemicals Limited (BOM:506935)
India · Delayed Price · Currency is INR 55.00
0.00 (0.00%)
At close: Nov 6, 2026
Continental Chemicals Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 2.6 | 2.55 | 2.23 | 4.24 | 4.39 | 4.79 |
Other Revenue | 0.88 | - | - | - | - | -0 |
| 3.48 | 2.55 | 2.23 | 4.24 | 4.39 | 4.79 | |
Revenue Growth | 50.00% | 14.70% | -47.50% | -3.40% | -8.36% | 146.50% |
Cost of Revenue | 5.42 | 5.42 | 5.48 | 5.07 | 5.04 | 4.66 |
Gross Profit | -1.94 | -2.86 | -3.25 | -0.83 | -0.65 | 0.13 |
Selling, General & Admin | -0.02 | 0.05 | 0.06 | 0.05 | 0.21 | 0.05 |
Other Operating Expenses | -7.06 | -8.3 | -7.26 | -6.29 | -3.62 | -0.68 |
Operating Expenses | -5.79 | -7.05 | -6.48 | -5.53 | -2.52 | 0.26 |
Operating Income | 3.85 | 4.18 | 3.23 | 4.7 | 1.87 | -0.13 |
Interest Expense | -0.44 | -0.43 | -0.38 | -0.36 | -0.33 | -0.37 |
Interest & Investment Income | 2.19 | 2.19 | 1.98 | 1.72 | 1.26 | 1.24 |
Currency Exchange Gain (Loss) | - | - | -0.01 | - | -0.04 | -0.01 |
Other Non Operating Income (Expenses) | 0 | -0 | - | 0 | - | 0 |
EBT Excluding Unusual Items | 5.6 | 5.95 | 4.82 | 6.06 | 2.76 | 0.73 |
Gain (Loss) on Sale of Assets | -0.07 | -0.07 | - | - | -0.01 | -0.03 |
Pretax Income | 5.53 | 5.88 | 4.82 | 6.06 | 2.75 | 0.71 |
Income Tax Expense | 0.73 | 0.76 | 0.46 | 0.87 | 0.26 | 0.11 |
Net Income | 4.8 | 5.12 | 4.36 | 5.18 | 2.49 | 0.6 |
Net Income to Common | 4.8 | 5.12 | 4.36 | 5.18 | 2.49 | 0.6 |
Net Income Growth | -13.37% | 17.43% | -15.86% | 107.78% | 316.36% | -58.23% |
Shares Outstanding (Basic) | 2 | 2 | 2 | 2 | 2 | 2 |
Shares Outstanding (Diluted) | 2 | 2 | 2 | 2 | 2 | 2 |
Shares Change | -0.36% | - | - | - | - | - |
EPS (Basic) | 2.14 | 2.28 | 1.94 | 2.30 | 1.11 | 0.27 |
EPS (Diluted) | 2.14 | 2.28 | 1.94 | 2.30 | 1.11 | 0.27 |
EPS Growth | -13.05% | 17.43% | -15.71% | 107.41% | 316.36% | -58.23% |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | 2.27 | -2.24 | -2.72 | 6.54 | -1.88 | 0.55 |
Free Cash Flow Per Share | 1.01 | -1.00 | -1.21 | 2.91 | -0.84 | 0.24 |
Gross Margin | -55.63% | -112.23% | -146.07% | -19.59% | -14.91% | 2.63% |
Operating Margin | 110.72% | 163.99% | 145.17% | 110.90% | 42.56% | -2.78% |
Profit Margin | 138.02% | 200.63% | 195.95% | 122.28% | 56.85% | 12.51% |
Free Cash Flow Margin | 65.11% | -87.89% | -122.20% | 154.25% | -42.88% | 11.39% |
EBITDA | 5.15 | 5.38 | 3.96 | 5.41 | 2.75 | 0.76 |
EBITDA Margin | 147.84% | 210.85% | 177.80% | 127.70% | 62.78% | 15.92% |
D&A For EBITDA | 1.29 | 1.2 | 0.73 | 0.71 | 0.89 | 0.9 |
EBIT | 3.85 | 4.18 | 3.23 | 4.7 | 1.87 | -0.13 |
EBIT Margin | 110.72% | 163.99% | 145.17% | 110.90% | 42.56% | -2.78% |
Effective Tax Rate | 13.15% | 12.85% | 9.53% | 14.42% | 9.28% | 15.16% |
Revenue as Reported | 17.71 | 16.78 | 15.74 | 15.75 | 12.66 | 10.41 |
Advertising Expenses | - | 0.05 | 0.06 | 0.05 | 0.21 | 0.05 |